Patents/Assignees

Xenothera

2 patents in portfolio

US12540184utility2026
Association of Polyclonal Antibodies and Anti-pd1 or Anti-pdl1 Antibodies for the Treatment of Cancer
0 cites
US11725044utility2023
Method for Producing Polyclonal Antibodies with Improved Complement-dependent Cytotoxicity
0 cites